PMID- 20005542 OWN - NLM STAT- MEDLINE DCOM- 20100611 LR - 20100524 IS - 1532-8600 (Electronic) IS - 0026-0495 (Linking) VI - 59 IP - 6 DP - 2010 Jun TI - Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentration after fat-rich meals: the Hoorn prandial study. PG - 854-60 LID - 10.1016/j.metabol.2009.10.002 [doi] AB - The aim of the study was to test whether fasting or postprandial cholesteryl ester transfer protein (CETP) concentrations are associated with postprandial changes in high-density lipoprotein cholesterol (HDL-c) concentrations after fat-rich or carbohydrate-rich meals. Postmenopausal women (76 with normal glucose metabolism [NGM], 41 with type 2 diabetes mellitus [T2DM], and 38 T2DM women with statin therapy [T2DM-ST]) received 2 consecutive fat-rich or carbohydrate-rich meals on separate occasions. Linear regression analysis was performed to assess the associations of fasting CETP and postprandial changes of CETP with postprandial changes in HDL-c. Mean plasma HDL-c concentrations decreased significantly after the fat-rich meals: 0.18 +/- 0.09 mmol/L in NGM, 0.16 +/- 0.09 mmol/L in T2DM, and 0.14 +/- 0.08 mmol/L in T2DM-ST women. This effect was smaller after using carbohydrate-rich meals: 0.12 +/- 0.09 mmol/L in the NGM, 0.12 +/- 0.08 mmol/L in the T2DM, and 0.10 +/- 0.05 mmol/L in the T2DM-ST study group. Higher fasting but not postprandial CETP concentrations were associated with a larger postprandial decrease in HDL-c (beta -0.034; 95% confidence interval, -0.067 to -0.001) after the fat-rich meals. This association was independent of the postprandial increase in triglycerides and similar among the 3 study groups. A high fasting CETP concentration may contribute to the postprandial atherogenic lipoprotein profile in postmenopausal women by decreasing HDL-c after fat-rich meals. This effect is independent from the postprandial increase in triglycerides. CI - Copyright 2010 Elsevier Inc. All rights reserved. FAU - Alssema, Marjan AU - Alssema M AD - EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands. m.alssema@vumc.nl FAU - El-Harchaoui, Karim AU - El-Harchaoui K FAU - Schindhelm, Roger K AU - Schindhelm RK FAU - Diamant, Michaela AU - Diamant M FAU - Nijpels, Giel AU - Nijpels G FAU - Kostense, Piet J AU - Kostense PJ FAU - Teerlink, Tom AU - Teerlink T FAU - Heine, Robert J AU - Heine RJ FAU - Dallinga-Thie, Geesje M AU - Dallinga-Thie GM FAU - Kuivenhoven, Jan A AU - Kuivenhoven JA FAU - Dekker, Jacqueline M AU - Dekker JM FAU - Scheffer, Peter G AU - Scheffer PG LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20091216 PL - United States TA - Metabolism JT - Metabolism: clinical and experimental JID - 0375267 RN - 0 (Cholesterol Ester Transfer Proteins) RN - 0 (Cholesterol, HDL) RN - 0 (Dietary Carbohydrates) RN - 0 (Dietary Fats) RN - 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors) RN - 0 (Triglycerides) SB - IM MH - Aged MH - Cholesterol Ester Transfer Proteins/*blood MH - Cholesterol, HDL/*blood MH - Diabetes Mellitus, Type 2/blood MH - Dietary Carbohydrates/pharmacology MH - Dietary Fats/*pharmacology MH - Fasting/blood MH - Female MH - Humans MH - Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use MH - Hypercholesterolemia/blood/drug therapy MH - Linear Models MH - Middle Aged MH - Postmenopause/metabolism MH - Postprandial Period/*physiology MH - Triglycerides/blood EDAT- 2009/12/17 06:00 MHDA- 2010/06/12 06:00 CRDT- 2009/12/17 06:00 PHST- 2009/07/07 00:00 [received] PHST- 2009/09/24 00:00 [revised] PHST- 2009/10/02 00:00 [accepted] PHST- 2009/12/17 06:00 [entrez] PHST- 2009/12/17 06:00 [pubmed] PHST- 2010/06/12 06:00 [medline] AID - S0026-0495(09)00425-9 [pii] AID - 10.1016/j.metabol.2009.10.002 [doi] PST - ppublish SO - Metabolism. 2010 Jun;59(6):854-60. doi: 10.1016/j.metabol.2009.10.002. Epub 2009 Dec 16.